Neutrophil-to-Lymphocyte Ratio, Lymphocyte-to-Monocyte Ratio, and Platelet-to-Lymphocyte Ratio in Erythema Nodosum Leprosum

Leprosy is a chronic, slowly progressive infectious disease caused by Mycobacterium leprae. The disease can cause extensive and permanent deformities of the skin and peripheral nerves, potentially resulting in severe and irreversible disabilities. A major challenge in the management of patients with leprosy is the development of leprosy reactions, which may occur at any stage of the disease. Identifying laboratory markers that can predict the occurrence and course of leprosy reactions remains a priority in leprosy research aimed at preventing irreversible nerve damage. This study aimed to determine the diagnostic value of inflammatory markers that may accurately indicate the severity of leprosy reactions. This study employed an analytical cross-sectional design. Samples were collected from patients who met the inclusion criteria at Haulussy Regional General Hospital and other affiliated hospitals and primary health centers in Ambon City, Maluku. A total of 20 samples were included. Blood samples were collected from the patients for laboratory analysis. The neutrophil-to-lymphocyte ratio, lymphocyte-to-monocyte ratio, and platelet-to-lymphocyte ratio were increased in patients with leprosy reactions; however, the differences were not statistically significant.

Authors

Institutions

Publication Details

Journal
Journal La Medihealtico
Published
2026-11-04
DOI
https://doi.org/10.37899/journallamedihealtico.v7i5.6026
Primary Topic
Leprosy Research and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Neutrophil-to-Lymphocyte Ratio, Lymphocyte-to-Monocyte Ratio, and Platelet-to-Lymphocyte Ratio in Erythema Nodosum Leprosum

Vina Zakiah Latuconsina, Amanda Gracia Manuputty, Fitri Kadarsih Bandjar
Journal La Medihealtico
Leprosy Research and Treatment
article

Neutrophil-to-Lymphocyte Ratio, Lymphocyte-to-Monocyte Ratio, and Platelet-to-Lymphocyte Ratio in Erythema Nodosum Leprosum

Vina Zakiah Latuconsina, Amanda Gracia Manuputty, Fitri Kadarsih Bandjar
article en

Abstract

Leprosy is a chronic, slowly progressive infectious disease caused by Mycobacterium leprae. The disease can cause extensive and permanent deformities of the skin and peripheral nerves, potentially resulting in severe and irreversible disabilities. A major challenge in the management of patients with leprosy is the development of leprosy reactions, which may occur at any stage of the disease. Identifying laboratory markers that can predict the occurrence and course of leprosy reactions remains a priority in leprosy research aimed at preventing irreversible nerve damage. This study aimed to determine the diagnostic value of inflammatory markers that may accurately indicate the severity of leprosy reactions. This study employed an analytical cross-sectional design. Samples were collected from patients who met the inclusion criteria at Haulussy Regional General Hospital and other affiliated hospitals and primary health centers in Ambon City, Maluku. A total of 20 samples were included. Blood samples were collected from the patients for laboratory analysis. The neutrophil-to-lymphocyte ratio, lymphocyte-to-monocyte ratio, and platelet-to-lymphocyte ratio were increased in patients with leprosy reactions; however, the differences were not statistically significant.

Journal La MedihealticoVol. 7(5)
University of Pattimura (ID)
Openalex Percentile: Top 13%
Leprosy Research and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon